VENOUS THROMBOEMBOLISM

This small pilot study aimed to see if a larger trial comparing two newer blood thinners (rivaroxaban and apixaban) for treating serious blood clots was possible. It enrolled 72 adults with newly diagnosed clots in their legs or lungs. The main goal was to test the process for a …

This study tested a device called the Protrieve Sheath, which acts like a safety net in a major vein. It was used during procedures to remove dangerous blood clots from the legs (DVT) to catch any broken-off pieces before they could travel to the lungs and cause a serious complic…

This study directly compared two common blood thinners, apixaban and rivaroxaban, to see which causes fewer serious bleeding problems when treating dangerous blood clots in the legs or lungs. Over 2,700 adults with newly diagnosed clots participated in this real-world trial. Rese…

This study tested a set of questions and a blood test (a 'clinical decision rule') to help doctors more accurately diagnose a new blood clot in patients who have had one before. It involved 744 adult outpatients who were suspected of having a repeat clot. The goal was to see if t…

This study tested if taking a low-dose blood thinner pill (apixaban) for a year could safely prevent dangerous blood clots from returning in high-risk patients. It involved 600 people who had a previous clot caused by a lasting health issue like obesity or heart failure. Particip…

This study tested an experimental drug, REGN7508, to see if it could safely prevent dangerous blood clots (venous thromboembolism) in adults after elective knee replacement surgery. It involved 179 participants and directly compared the new drug to an existing standard treatment.…

This study tested whether a small, wearable leg stimulator (called Geko) is a practical alternative to standard compression sleeves for preventing blood clots in critically ill adults. Researchers compared the two methods in 40 patients to see if the new device could be reliably …

This study aimed to understand if people with a history of dangerous blood clots (venous thromboembolism) have specific, age-related mutations in their blood cells. Researchers tested DNA from 150 patients over 50 years old who had experienced clots. The goal was to gather knowle…

This study aimed to measure how often blood clots form in patients with serious pelvic and hip socket fractures while they are in the hospital. Researchers followed 81 adult patients who received a standard blood-thinning medication to prevent clots. They used ultrasound scans to…

This study aimed to understand how two potential blood markers for dangerous blood clots (venous thromboembolism) change over time. Researchers measured these markers monthly for six months in 15 healthy volunteers and 15 people with a history of blood clots. The goal was to see …

This study aimed to understand the real-life experiences of children and young adults with blood disorders like clotting problems or bleeding conditions. Researchers interviewed 15 participants aged 12-21 about how their condition affects their daily life, emotions, and future pl…

This study followed 1000 adults diagnosed with blood clots (venous thromboembolism) over time to gather information. The goal was to understand which patients are most likely to have another clot and which patients might safely stop long-term blood-thinning medication to avoid bl…